Cancer Research UK's Tim Hunt appointed to European research body
The Cancer Research UK biochemist is one of seven new members appointed by the European Commission to the council, which sets the scientific policy of the ERC - the European funding body set up to support research.
Sir Tim has been working with Cancer Research UK since 1990 and leads the cell cycle control laboratory at the charity's London Research Institute.
His work focuses on understanding how proteins called cyclin-dependent protein kinases (CDKs) control cell division, and how the cell controls when cyclins are destroyed at different stages of the cell cycle.
Discovering how cells grow and divide is vital for cancer research, as cancer develops when cells multiply out of control.
Sir Tim - who was a joint recipient of the Nobel Prize for Medicine in 2001 - will sit on the Scientific Council from February 2nd 2011 until the end of 2013.
News of Sir Tim's appointment was welcomed by Harpal Kumar, Cancer Research UK's chief executive.
He said: "We are delighted that one of our most eminent scientists has been appointed to this important role.
"He brings an exceptional wealth of research experience and expertise from his world-leading work on the control of the cell cycle - the process by which all cells multiply.
"His many important discoveries in this area have contributed greatly to our knowledge of how cancer develops and the routes by which we can detect and treat the disease. This understanding is crucial in our work to develop new ways to beat cancer and increase survival."